$JNJ Company News Ebola-nation travelers to U.S. to be

New Post Public Reply Private Reply Replies (0) Message Board

Oct 23, 2014 at 1:46 PM

$JNJ Company News

Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
The market in a minute: Schizophrenic action 12:40 p.m. Oct. 13, 2014 - The Trading Deck
Earnings under pressure from stronger U.S. dollar 5:30 a.m. Oct. 12, 2014 - Wallace Witkowski

3M the Cash Generation Machine in the Industrials Segment 11:53 a.m. Today - GuruFocus.com
My Dividend Stocks Aren't For Sale 5:04 a.m. Today - Seeking Alpha
'Fast Money' Recap: Look to Exxon Mobil as Oil Continues Lower 5:00 a.m. Today - TheStreet.com
The New Nifty Fifty, Part 2: Dividend Growth Investing's Greatest Hits 10:15 p.m. Oct. 22, 2014 - Seeking Alpha
Time In The Market Is More Important Than Timing The Market 8:57 p.m. Oct. 22, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Goldman Sachs Group (GS) Lags 4:30 p.m. Oct. 22, 2014 - TheStreet.com
The Income Buffer In Relation To Price Declines 2:23 p.m. Oct. 22, 2014 - Seeking Alpha
The Bloggers' Dividend Growth Portfolio: Popular Dividend Growth Stocks Trading On U.S. Exchanges 2:18 p.m. Oct. 22, 2014 - Seeking Alpha
Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog 1:54 p.m. Oct. 22, 2014 - Zacks.com
Dividend Aristocrats In Focus Part 24: Consolidated Edison 1:43 p.m. Oct. 22, 2014 - GuruFocus.com
3 Drugs Stocks Pushing The Industry Higher 1:03 p.m. Oct. 22, 2014 - TheStreet.com
EC approves ulcerative colitis med 11:31 a.m. Oct. 22, 2014 - Seeking Alpha
JNJ and GSK Working on Ebola Vaccines 9:42 a.m. Oct. 22, 2014 - InvestorPlace.com
J&J to Test Ebola Vaccine in January 8:45 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Why Johnson & Johnson (JNJ) Stock Is Higher Today 7:45 a.m. Oct. 22, 2014 - TheStreet.com
October 22 Premarket Briefing: 10 Things You Should Know 6:36 a.m. Oct. 22, 2014 - TheStreet.com
Wall Street Breakfast: Bank Of England Keeps Rates Low 6:32 a.m. Oct. 22, 2014 - Seeking Alpha
Dispatches: Ebola News Digest 1:53 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Gilead Sciences: Pricing, Politics And Profits 3:23 p.m. Oct. 21, 2014 - Seeking Alpha
Celgene Reports More Good Crohn's Disease Data 10:32 a.m. Oct. 21, 2014 - Investors Business Daily

Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Today - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Post-Earnings Insight - Johnson and Johnson 9:05 a.m. Oct. 16, 2014 - PR Newswire - PRF
Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board 8:03 a.m. Oct. 16, 2014 - PR Newswire - PRF
Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies 8:01 a.m. Oct. 16, 2014 - BusinessWire - BZX
Spine Wave Announces Addition to the Executive Management Team 8:01 a.m. Oct. 16, 2014 - Marketwired
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2014 7:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Johnson & Johnson Family of Consumer Companies Turns Brands Purple in Support of Spirit Day 9:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
China Diagnostic Reagent Industry Report, 2013-2016 6:53 p.m. Oct. 14, 2014 - PR Newswire - PRF
Critical Alerts For Digital River, Cheniere Energy, Intel, US Ecology Inc and Johnson & Johnson Released By InvestorsObserver 9:31 a.m. Oct. 13, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek 8:31 a.m. Oct. 13, 2014 - Marketwired
SHPE Presents 2014 STAR Award Company of the Year to Johnson & Johnson and Government Agency of the Year to U.S. Army 12:00 p.m. Oct. 8, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

When Families Should Consider Life Insurance Plans

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Greenland Energy Board Reshuffle: McIllree Exits

A Change in Greenland Energy's Lineup Well, folks, the wheel keeps turning at Greenland Energy Company (NASDAQ:GLND). Roderick McIllree has decided to step off the Board of Directors' carousel, effective immediately. And nope, there wasn't a classic showdown or any disagreement on the table. This exit is as drama-free as they come—just him stepping aside, leaving the...

Tampa General's Tech Triumphs in Healthcare Innovation

Spotlight on Tampa General's Technological Edge Wow, just when you think you've seen it all in the healthcare sector, here comes Tampa General Hospital (TGH) shaking things up again. Making waves by earning a spot among the "World's Best Smart Hospitals for 2027" by Newsweek and Statista, TGH's proving that tech-savvy isn't just for Silicon Valley startups. Folks, being...

Unicycive Faces Legal Heat: Investors Eye Key Deadline

What Went Wrong with Unicycive? Unicycive Therapeutics, Inc., a player in the biotech space, finds itself embroiled in a legal quagmire. A class action lawsuit is hovering over NASDAQ:UNCY, spurred by allegations of the company's slip-ups in manufacturing oversight. Investors are ticked off, understandably, as the lawsuit zeroes in on failures to resolve FDA-cited issues....

College Athletics Needs a New Business Revolution

Wake Up Call for College Athletics Here's a heads-up—college sports aren't just about cheering fans and game-day jerseys anymore. It's high time universities start thinking of athletics as businesses, blending the thrill of game day with the realities of financial statements. Michael Schreiber rang this bell loud and clear on the 'Disruption Interruption' podcast,...

French Florist Blossoms in Los Gatos This October

A New Floral Journey Blooms in Los Gatos October's shaping up to be a vibrant month for Los Gatos, as a slice of French elegance arrives courtesy of Anhelina Baftalovska. She's not just bringing flowers; she's introducing a unique blend of life passions and entrepreneurial spirit to the community. Let's dig into this delightful story of blooms and business. A Ukrainian's...

Corra Group Enhances Hiring with Digital I-9 Services

The Changing Landscape of Employment Verification Employment verification is no longer a mere formality with a paper form. Now, it’s a digital jungle, where missing a deadline isn't just a slap on the wrist, but a compliance nightmare. In steps Corra Group, bringing electronic I-9 tools to the frontlines, geared to help employers juggle the mess of forms, deadlines, and...

Venture Dock Fosters Global Startup Ecosystems

Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...

Ecopetrol Ushers New Executive Leadership for Transition

New Blood Steering the Energy Transition Let's crack open the vault on Ecopetrol's recent maneuver: Armando José Cuello Navarro is stepping up as the new Executive Vice President of Energy Transition. It's like handing the wheel to a seasoned driver in a storm—this guy’s got the chops to navigate Colombia's energy maze. Cuello's resume reads like a textbook on energy...

Visteon Reports Q3 2026 Results with Mixed Signals

Visteon's Q3 2026 Financial Performance: Insights and Implications You'd think by now that anything to do with supply chain hiccups wouldn’t surprise me, but Visteon Corporation’s recent third quarter results got my gears grinding yet again. Here's the scoop: Visteon pulled in $970 million in sales, strutting around with a 10% growth-over-market. Their resilience...